Novel MET/TIE2/VEGFR2 inhibitor altiratinib inhibits tumor growth and invasiveness in bevacizumab-resistant glioblastoma mouse models

Yuji Piao, Soon Young Park, Verlene Henry, Bryan D. Smith, Ningyi Tiao, Daniel L. Flynn, John F. De Groot

Research output: Contribution to journal › Review article › peer-review

51 Scopus citations

Fingerprint

Dive into the research topics of 'Novel MET/TIE2/VEGFR2 inhibitor altiratinib inhibits tumor growth and invasiveness in bevacizumab-resistant glioblastoma mouse models'. Together they form a unique fingerprint.

Medicine & Life Sciences